Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence and Prognostic Significance of T Wave Alternans in Patients With Severe Congestive Heart Failture

NCT00006501 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT00006501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence and Prognostic Significance of T Wave Alternans in Patients With Severe Congestive Heart Failture
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
January 31, 2003
Completion date
February 29, 2012
Enrollment
549 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

death, sudden, cardiac, heart arrest, heart diseases, ventricular arrhythmia, ventricular fibrillation